RADNOR, Pa.--(BUSINESS WIRE)-- #classaction--The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Replimune Group, Inc. (āReplimuneā) (NASDAQ: REPL) on behalf of those who purchased or otherwise acquired Replimune securities between November 22, 2024, and July 21, 2025, inclusive (the āClass Periodā). The lead plaintiff deadline is September 22, 2025. CONTACT KESSLER TOPAZ MELTZER & CHECK, LLP: If you suffered
Related Questions
Could this legal action trigger a review or downgrade by analysts covering REPL?
What precedent does this lawsuit set compared to similar cases in the biotech sector?
How does the timing of the lead plaintiff deadline (SeptāÆ22āÆ2025) affect the risk profile for current shareholders?
Are there any disclosed details about the alleged securities violations that could affect REPL's business outlook?
Might this litigation lead to a material adverse change (MAC) clause activation in any of REPL's existing contracts?
What potential effect will the securities class action lawsuit have on REPL's short-term stock price?
What are the possible financial liabilities or settlement costs for Replimune if the case proceeds?
Will the lawsuit impact Replimune's ability to raise capital or secure financing in the near future?
How should position sizing and stopāloss levels be adjusted in response to this development?
How might the lawsuit influence investor sentiment and trading volume for REPL?